| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 13 Dec 24 | NVAX Novavax | Common Stock | Sell | Dispose S | No | No | 9.0205 | 4,150 | 37.44 k | 14,770 |
| 12 Nov 24 | FULC Fulcrum Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.64 | 60,000 | 218.40 k | 60,000 |
| 12 Jun 24 | NVAX Novavax | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,670 | 0.00 | 18,920 |
| 12 Jun 24 | NVAX Novavax | RSU Common Stock | Grant | Acquire A | No | No | 0 | 10,420 | 0.00 | 10,420 |
| 12 Jun 24 | NVAX Novavax | Stock Option Common Stock | Grant | Acquire A | No | No | 15.86 | 15,630 | 247.89 k | 15,630 |
| 12 Jun 24 | NVAX Novavax | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 6,670 | 0.00 | 0 |
| 1 May 24 | GLYC GlycoMimetics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.62 | 40,000 | 64.80 k | 40,000 |
